About Us:

Simba Discovery is a pre-clinical stage company committed to developing innovative non-antibiotic therapeutics for the treatment of bacterial infections. The focus is on targeting bacterial adhesion proteins, which facilitate the attachment of bacteria to host cells, playing a crucial role in the establishment of infections. Simba Discovery aims to provide new and effective treatments that do not rely on antibiotics by disrupting the adhesion process.